Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma.

Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma.
复制标题

DOI:
10.1093/bjs/znab460
复制
发表时间:
2022-02-24
期刊:
The British journal of surgery
影响因子:
--
通讯作者:
--
中科院分区:
其他
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

Epstein-Barr病毒阳性胃癌患者或微卫星不稳定患者预后良好。然而,染色体状态(染色体稳定(CS)与染色体不稳定(CIN))在胃癌中的预后价值尚不清楚。在一项包括胃癌患者试验和验证队列的回顾性研究中,测定了16个cin相关基因的基因拷贝数畸变(CNAs)。患者被分为CS(无CNA)、CINlow(1-2个CNA)和CINhigh(3个或更多CNA)。分析染色体状态、临床病理变量与总生存期(OS)的关系。染色体状态、p53表达和肿瘤浸润免疫细胞之间的关系也被评估和外部验证。试验和验证队列分别包括206例和748例患者。在试验队列中,CINlow和CINhigh分别出现在35.0%和15.0%的患者中,在验证队列中分别出现在48.5%和20.7%的患者中。在试验和验证队列中,CINhigh胃癌患者的OS最低。在多变量分析中,CINlow、CINhigh和pTNM III-IV期(P < 0.001)与不良OS独立相关。CIN与p53高表达和免疫细胞浸润低相关。CIN可能是一种潜在的新的独立于pTNM分期的胃癌预后生物标志物。显示CIN的胃癌患者似乎免疫抑制,这可能是解释低生存率的潜在机制之一,并可能有助于指导未来的治疗决策。
Patients with Epstein–Barr virus-positive gastric cancers or those with microsatellite instability appear to have a favourable prognosis. However, the prognostic value of the chromosomal status (chromosome-stable (CS) versus chromosomal instable (CIN)) remains unclear in gastric cancer. Gene copy number aberrations (CNAs) were determined in 16 CIN-associated genes in a retrospective study including test and validation cohorts of patients with gastric cancer. Patients were stratified into CS (no CNA), CINlow (1–2 CNAs) or CINhigh (3 or more CNAs). The relationship between chromosomal status, clinicopathological variables, and overall survival (OS) was analysed. The relationship between chromosomal status, p53 expression, and tumour infiltrating immune cells was also assessed and validated externally. The test and validation cohorts included 206 and 748 patients, respectively. CINlow and CINhigh were seen in 35.0 and 15.0 per cent of patients, respectively, in the test cohort, and 48.5 and 20.7 per cent in the validation cohort. Patients with CINhigh gastric cancer had the poorest OS in the test and validation cohorts. In multivariable analysis, CINlow, CINhigh and pTNM stage III–IV (P < 0.001) were independently associated with poor OS. CIN was associated with high p53 expression and low immune cell infiltration. CIN may be a potential new prognostic biomarker independent of pTNM stage in gastric cancer. Patients with gastric cancer demonstrating CIN appear to be immunosuppressed, which might represent one of the underlying mechanisms explaining the poor survival and may help guide future therapeutic decisions.
DOI: 10.1136/gutjnl-2011-301839
发表时间: 2012-05
期刊: Gut
影响因子: 24.5
作者:
Deng N;Goh LK;Wang H;Das K;Tao J;Tan IB;Zhang S;Lee M;Wu J;Lim KH;Lei Z;Goh G;Lim QY;Tan AL;Sin Poh DY;Riahi S;Bell S;Shi MM;Linnartz R;Zhu F;Yeoh KG;Toh HC;Yong WP;Cheong HC;Rha SY;Boussioutas A;Grabsch H;Rozen S;Tan P
通讯作者: Tan P
DOI: 10.1016/j.neo.2017.02.012
发表时间: 2017-05
期刊: Neoplasia (New York, N.Y.)
影响因子: --
作者:
Maleki SS;Röcken C
通讯作者: Röcken C
染色体不稳定性通过胞质DNA反应驱动转移。
DOI: 10.1038/nature25432
发表时间: 2018-01-25
期刊: Nature
影响因子: 64.8
作者:
Bakhoum SF;Ngo B;Laughney AM;Cavallo JA;Murphy CJ;Ly P;Shah P;Sriram RK;Watkins TBK;Taunk NK;Duran M;Pauli C;Shaw C;Chadalavada K;Rajasekhar VK;Genovese G;Venkatesan S;Birkbak NJ;McGranahan N;Lundquist M;LaPlant Q;Healey JH;Elemento O;Chung CH;Lee NY;Imielenski M;Nanjangud G;Pe'er D;Cleveland DW;Powell SN;Lammerding J;Swanton C;Cantley LC
通讯作者: Cantley LC
DOI: 10.1038/nature20805
发表时间: 2017-01-12
期刊: Nature
影响因子: 64.8
作者:
Cancer Genome Atlas Research Network;Analysis Working Group: Asan University;BC Cancer Agency;Brigham and Women’s Hospital;Broad Institute;Brown University;Case Western Reserve University;Dana-Farber Cancer Institute;Duke University;Greater Poland Cancer Centre;Harvard Medical School;Institute for Systems Biology;KU Leuven;Mayo Clinic;Memorial Sloan Kettering Cancer Center;National Cancer Institute;Nationwide Children’s Hospital;Stanford University;University of Alabama;University of Michigan;University of North Carolina;University of Pittsburgh;University of Rochester;University of Southern California;University of Texas MD Anderson Cancer Center;University of Washington;Van Andel Research Institute;Vanderbilt University;Washington University;Genome Sequencing Center: Broad Institute;Washington University in St. Louis;Genome Characterization Centers: BC Cancer Agency;Broad Institute;Harvard Medical School;Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University;University of North Carolina;University of Southern California Epigenome Center;University of Texas MD Anderson Cancer Center;Van Andel Research Institute;Genome Data Analysis Centers: Broad Institute;Brown University:;Harvard Medical School;Institute for Systems Biology;Memorial Sloan Kettering Cancer Center;University of California Santa Cruz;University of Texas MD Anderson Cancer Center;Biospecimen Core Resource: International Genomics Consortium;Research Institute at Nationwide Children’s Hospital;Tissue Source Sites: Analytic Biologic Services;Asan Medical Center;Asterand Bioscience;Barretos Cancer Hospital;BioreclamationIVT;Botkin Municipal Clinic;Chonnam National University Medical School;Christiana Care Health System;Cureline;Duke University;Emory University;Erasmus University;Indiana University School of Medicine;Institute of Oncology of Moldova;International Genomics Consortium;Invidumed;Israelitisches Krankenhaus Hamburg;Keimyung University School of Medicine;Memorial Sloan Kettering Cancer Center;National Cancer Center Goyang;Ontario Tumour Bank;Peter MacCallum Cancer Centre;Pusan National University Medical School;Ribeirão Preto Medical School;St. Joseph’s Hospital &Medical Center;St. Petersburg Academic University;Tayside Tissue Bank;University of Dundee;University of Kansas Medical Center;University of Michigan;University of North Carolina at Chapel Hill;University of Pittsburgh School of Medicine;University of Texas MD Anderson Cancer Center;Disease Working Group: Duke University;Memorial Sloan Kettering Cancer Center;National Cancer Institute;University of Texas MD Anderson Cancer Center;Yonsei University College of Medicine;Data Coordination Center: CSRA Inc.;Project Team: National Institutes of Health
通讯作者: Project Team: National Institutes of Health
DOI: 10.1186/1471-2105-11-67
发表时间: 2010-01-29
期刊: BMC bioinformatics
影响因子: 3
作者:
van Eijk R;Eilers PH;Natté R;Cleton-Jansen AM;Morreau H;van Wezel T;Oosting J
通讯作者: Oosting J